22nd Century Q3 revenue up 148% to $19.4M; net loss $13.1M, VLN expansion to 12-18 states

22nd Century Group, Inc.

2022-Q3 EPS reported -$0.18 revenue$42,905,000

Net revenue $19.4M (+148% YoY); tobacco $11.5M (+47.7%), hemp/cannabis $7.8M (new).
Operating loss widened to $15.3M from $7.6M; net loss $13.1M ($0.06/share).
VLN cigarette launch expands to CO, AZ, NM, UT; targeting 12-18 states within 12 months.
Full quarter of GVB Biopharma revenue included; GVB passed NSF audit, pursuing pharma-grade certifications.
Cash and investments $43.7M; manufacturing capacity +25%; largest VLN tobacco crop planted.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

22nd Century Group, Inc. reported the third quarter ended September 30, 2022 results: revenue $19.4 Million.

Period: the third quarter ended September 30, 2022
Revenue: $19.4 Million
Result: reported results

Exact text from the filing

and Illinois, Launching in Four Corners States to Capture Market Share and Volume ● GVB Biopharma Acquisition Growing Revenue on Increased Volumes ● Third Quarter Net Sales $19.4 Million, Up 148% from the Third Quarter 2021 ● Strong Balance Sheet to Support Strategic Initiatives Including Accelerated VLN ® Expansion BUFFALO, N.Y., November 8, 2022 (Globe

View on SEC.gov

39 earnings releases filed in the last 30 days. Browse all earnings releases →

22nd Century Group, Inc. filing history →

Source: SEC EDGAR

accession 0001558370-22-016725

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.